Buying

How Long ErecPower Takes: The 3-To-4-Week Record

Reviewed by Dr. Goldwyn Foggie (Dr. Goldie), MD

Three to four weeks on this desk’s own record of 996 reviews. Why week one is nothing, why a fast result would be worrying, and which pack actually fits a sixty-day window.

The three numbers, and how they fit

Three figures decide everything about how to buy and judge this product, and unlike most products in this category they do fit together.

• Three to four weeks. The typical wait recorded in the supplier's material for this stock, across 996 written reviews and 9,110 orders.
• Sixty days. The money-back window, running from the date of purchase.
• Thirty capsules. One bottle, one month, at one a day.

A sixty-day window comfortably contains a three-to-four-week wait. That is not true of every product: a thirty-day guarantee on something that takes six weeks is a guarantee designed not to be used. Here the numbers line up, and it is the single best thing about this label. The guarantee page has the terms in full.

Week by week

Day counts come from the eight-reviewer roster published in full on the reviews page.

What the roster actually shows

Eight reviewers, with day counts attached: 14, 16, 25, 28, 32, 36, 37 and 55. Seven of the eight gave five stars, one gave three.

The useful pattern is the earliest and the latest. Nobody wrote before day 14, which is consistent with a product that does nothing in week one. The spread out to day 55 is wide, and the three-star review sits at day 37, which is past the point where the record says most people notice something. That last detail is what makes it a useful review rather than an impatient one.

There is a caveat that belongs here rather than in a footnote. Those eight reviewers carry two distinct sentences between them, and the pack this desk works from says outright that its review copy is layout copy. The ages, cities, pack sizes and day counts are specific and varied and worth publishing; the sentences are summary categories. The reviews page is built around that distinction and explains why no per-person review markup is emitted anywhere on this website.

Why it is slow, and why fast would be worrying

None of the mechanisms on this panel is acute. The pooled tongkat ali trials measured testosterone over weeks of daily dosing. The hawthorn trial record runs over weeks to months. The icariin work behind epimedium is laboratory work with no human timeline at all.

So a slow start is the expected behaviour of a botanical formula rather than a fault in it. And the inverse is the part worth finishing: Tucker 2018, analysing the FDA's warning record, found unapproved pharmaceutical ingredients in hundreds of supplements sold for sexual enhancement, sildenafil and its analogues most commonly. A herbal capsule that works within an hour is behaving like a drug, and the reasonable response to that is to stop and take it to a clinician rather than to reorder.

How to judge it without fooling yourself

The thing being measured here is subjective, variable and easy to misremember. Four habits make a four-week trial produce a readable answer.

• One line a week, not one a day. Daily monitoring becomes a factor in its own right in this area and it makes a trend harder to see.
• Record sleep and alcohol beside it. Both move this outcome more than most supplements do. The 2022 scoping review of non-drug approaches is blunt about how much the ordinary inputs matter.
• Change one thing at a time. A gym routine started in week two owns the week-four verdict.
• Expect regression to the mean. People buy a product like this after a bad run, and a bad run is usually followed by an ordinary one whatever you take.

What a four-week trial cannot tell you

One person, one product, one month, no control group and no blinding. That is not a reason to skip it, because it is the only experiment available to you. It is a reason to know what it can carry.

It can tell you whether you tolerate the capsule, which is a real answer and arrives quickly. It can tell you whether the routine is sustainable, which is what seven of the eight reviewers on this roster actually reported. It cannot separate the capsule from expectation, from a good month’s sleep or from the attention that comes with paying attention. And it cannot detect a small effect: a change of a few per cent is invisible to one person over four weeks, which is what trials with hundreds of participants exist for.

NCCIH's Know the Science pages are a good short course in this kind of reasoning, and they are more useful than anything on this website for reading the next supplement page you land on.

What the timeline means for which pack to buy

Prices read from the seller's own page on 17 September 2026. The right-hand column is the one to read: six bottles is the cheapest per day at $1.63 and leaves 120 days of product you cannot send back. The pricing page has the full arithmetic.

This desk suggests three bottles for a first order. It is not the cheapest per day, it is not the seller’s Best Value, and it is not the pack we earn most on. It is the one that lets you run the trial properly and still decide inside the window.

When to stop

At day 50, if nothing has changed. That is what the window is for, and one reviewer on this desk’s roster did exactly that: three stars, day 37, called the desk, stopped at two bottles. It is the most useful entry in the record.

Stop sooner if anything feels wrong. There is no tapering requirement on a botanical capsule and nothing to withdraw from. Keep the bottle, and if you feel unwell take it to a clinician, because the label is what they will want to read.

And stop, or rather do not start, if the underlying question is medical. The NIDDK's list of causes is mostly made of things a clinician can measure and often treat. A month spent waiting on a supplement is a month not spent finding that out.

The verdict

Three to four weeks, week one reliably nothing, and a decision at day 50. That is the whole timeline, it comes from this desk’s own order record rather than from a clinical trial, and it is stated here with that limitation attached.

The commercially awkward part, which is why this article exists: the pack that fits that timeline is not the pack that pays us most. The pricing page says the same thing with the numbers, and the results timeline page is the shorter version of this article.